Tracked deals
28
28 tracked deals across 2006-2026.
Boston, MA, United States
Parthenon Capital Partners (Parthenon Capital) is a growth-focused private equity firm that partners with management teams and invests in their companies using a research-driven approach within core sectors, creating value through both acquisitive and organic strategies.
Tracked deals
28
28 tracked deals across 2006-2026.
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Growth capital
10 growth capital · 7 addon · 7 buyout
Last 8 years
Supporting Data
Showing the 12 most recent of 28 tracked deals for Parthenon Capital.
Momentum Life Sciences announced a strategic growth investment from Parthenon Capital; financial terms were not disclosed. The capital is intended to accelerate Momentum’s growth strategy and pursue strategic acquisitions across the specialty-therapy commercialization ecosystem focused on patient initiation and adherence.
Parthenon Capital has made a strategic growth investment in Embark, a Dallas-based management and financial consulting firm, to accelerate the company's organic growth and M&A strategy while expanding its technology and AI capabilities. Founder Paul Allen will remain Chairman and retain a significant ownership stake as Embark pursues investments in automation, AI, talent, and expanded advisory services.
Audax Private Equity and Parthenon Capital have acquired Elevate Patient Financial Solutions (formerly MedData) from Frazier Healthcare Partners in a transaction that closed July 31, 2025. Elevate, headquartered in Spring, Texas, is a technology-enabled provider of specialty revenue cycle management (RCM) services for hospitals and health systems; the investment will support organic growth and future add-on acquisitions to expand the company’s front-end and back-end RCM capabilities.
Parthenon Capital has made a strategic growth investment in AArete, a Chicago-based management and technology consulting firm specializing in profitability improvement and digital transformation for healthcare payers, financial services and the public sector. The capital will be used to accelerate growth initiatives, broaden AArete’s service offerings, and support acquisitions while existing employees and leaders remain significant shareholders.
MRO Corp. has acquired Q-Centrix Corp., an enterprise clinical data management platform, from TPG Growth. The transaction is supported by Parthenon Capital, which made a new investment in MRO to back the combined company's growth; financial terms were not disclosed.
Parthenon Capital has made a strategic growth investment in Medical Review Institute of America (MRIoA), a Salt Lake City–based provider of utilization management and clinical review solutions for payers. Summit Partners and MRIoA management will retain significant positions following the transaction; financial terms were not disclosed. Mizuho (and affiliate Greenhill & Co.) served as MRIoA's financial advisor and Kirkland & Ellis advised Parthenon.
Parthenon Capital has acquired the gaming division of Global Payments Inc., transitioning Global Payments Gaming Solutions into an independent company renamed Pavilion Payments. The carve-out will be headquartered in Las Vegas and Parthenon intends to grow the business organically and via acquisitions while Global Payments remains a long-term technology partner.
Parthenon Capital has acquired a majority stake in Titan Wealth, partnering with the management team to support further organic growth, technology investment and future M&A. The transaction delivers a partial exit for Maven's UK Regional Buyout Fund (with a material return) while existing investors including funds managed by Ares and Maven remain committed to the business.
Smart Data Solutions (SDS), a Parthenon Capital–backed healthcare automation provider, has acquired JMS and Associates, a Farmington Hills, Michigan provider of tech-enabled outsourced solutions for TPAs and other healthcare organizations. The acquisition expands SDS's claims processing, data capture and plan-building capabilities and brings JMS's leadership team and clients into the SDS organization.
Parthenon Capital has made a strategic, growth-oriented investment in Cherry Bekaert to support the firm's business advisory practices, funding technology, infrastructure, and expansion initiatives. The transaction restructures Cherry Bekaert into Cherry Bekaert LLP (attest services) and Cherry Bekaert Advisory LLC (business advisory/non-attest services) and is intended to accelerate organic growth and enable strategic acquisitions.
Payroc WorldAccess (Payroc), a PE-backed global payments acquirer, has acquired Worldnet, a provider of unified omnichannel payments gateway solutions for ISVs. The deal — completed with support from Payroc’s sponsor Parthenon Capital — expands Payroc’s embedded payments and ISV capabilities and brings Worldnet’s online, in‑store, unattended, and mobile payment technology onto Payroc’s platform.
Parthenon Capital, together with Choreo management and advisors, acquired RSM US Wealth Management LLC from RSM US LLP and renamed the business Choreo, LLC. The deal was designed to preserve the client-first, planning-centric approach while funding additional investment in people, technology, recruiting, and growth through organic expansion and acquisitions.
Turn tracked acquisition activity into an outreach-ready buyer list.